ABSTRACT
Frozen shoulder contracture syndrome (FSCS) is characterized by underhand onset, severe shoulder daily and night pain, active and passive range of motion (ROM) limitation, disturbing sleep, and shoulder-related disability.
FSCS has a cryptogenetics etiology and is more prevalent in people with diabetes, autoimmune and thyroid disease, with higher prevalence in the age range between 50 and 60. Notably no deal is about higher incidence in people with physically low activity and female sex. Moreover, although some patients report complete symptom recovery, others report residual motion impairments and pain.
Research on prognostic factors was applied on FSCS, and Eljabu et colleagues (2016) stated that diabetes, comorbidities, bilateral presentation and onset higher pain and disability are negative prognostic factors that could direct patient to early surgery; however, little is known about the prognostic influence of psychological factors in FSCS patients. On the other hand, in other shoulder pathologies, the presence of psychological factors is well documented, and evidence confirms that some of these features could represent prognostic factors that impact the prognosis.
A recent systematic review reported that psychological factors were associated with increased pain perception and decreased function and quality of life at baseline in patients with FSCS, and pain-beliefs seem to be associated with a worst perception of arm function; however, little is known about the prognostic value of such factors in FSCS recovery.
Knowing about the presence and the role of all types of prognostic factors is important because they can aid treatment and lifestyle decisions, improving individual risk prediction, providing novel targets for new treatments, and enhancing collaboration between different professionals.
This study aims to determine if pain, function, disability, quality of life, ROM and time for recovery were influenced by psychological factors in FSCS patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Universita degli studi del Molise gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funder No funding was provided for this study
Data Availability
All data produced in the present study are available upon reasonable request to the authors
